Nanexa AB - Home

VISION & MISSION

Nanexa will be a world leading drug development company for Long Acting Injectables, developing a new generation of innovative drug products enabled by our unique PharmaShell® technology”

In its state-of-the-art pilot plant and labs in Uppsala, Nanexa runs the development of own product projects and collaborative projects with other pharmaceutical companies, based on the PharmaShell® system.

PRESSRELEASES

11 April, 2025

Notice of annual general meeting in Nanexa AB (publ)

The shareholders in Nanexa AB (publ),reg.no 556833–0285 (the ”Company”) are hereby given notice that the annual general meeting will be held on Thursday 15 May 2025, at. 3:00 pm, at Uppsala Business Park, Rapsgatan 7, Uppsala, Sweden.

10 April, 2025

Nanexa publishes annual report for 2024

Nanexa AB (publ) today announces that the annual report for 2024 has been published and is available on the company’s website https://nanexa.com/en/financial-reports.